Prototype demonstrates superior bladder volume monitoring using machine learning, suggesting improved patient experience.
Neurogenic bladder is a debilitating condition caused by neurological dysfunction that impairs urinary control, often requiring timed intermittent catheterisation. Although effective, intermittent catheterisation is invasive, uncomfortable, and associated with infection risks, reducing patients’ quality of life. SafeBladder is a low-cost wearable device developed to enable real-time, non-invasive bladder volume monitoring using near-infrared spectroscopy (NIRS) and machine learning algorithms. The prototype employs LEDs and photodetectors to measure light attenuation through abdominal tissues. Bladder filling was simulated through experimental tests using stepwise water additions to containers and tissue-mimicking phantoms, including silicone and porcine tissue. Machine learning models, including Linear Regression, Support Vector Regression, and Random Forest, were trained to predict volume from sensor data. The results showed the device is sensitive to volume changes, though ambient light interference affected accuracy, suggesting optimal use under clothing or in low-light conditions. The Random Forest model outperformed others, with a Mean Absolute Error (MAE) of 25 ± 4 mL and R2 of 0.90 in phantom tests. These findings support SafeBladder as a promising, non-invasive solution for bladder monitoring, with clinical potential pending further calibration and validation in real-world settings.
No takes yet. Share an insight, caveat, or question.
Sousa et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: